Literature DB >> 1864281

Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori.

S Suerbaum, H Leying, K Klemm, W Opferkuch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1864281     DOI： 10.1007/bf01964416

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer.

Authors:  G Biasco; M Miglioli; L Barbara; R Corinaldesi; G di Febo
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

2.  Omeprazole, campylobacter pylori, and duodenal ulcer.

Authors:  P Mainguet; M Delmée; J C Debongnie
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

3.  The mechanism of action of the gastric acid secretion inhibitor omeprazole.

Authors:  P Lindberg; P Nordberg; T Alminger; A Brändström; B Wallmark
Journal:  J Med Chem       Date:  1986-08       Impact factor: 7.446

Review 4.  The physiology of gastric acid secretion.

Authors:  M M Wolfe; A H Soll
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

5.  In vivo susceptibility of Campylobacter pylori.

Authors:  D Y Graham; P D Klein; A R Opekun; K E Smith; R R Polasani; D J Evans; D G Evans; L C Alpert; P A Michaletz; H H Yoshimura
Journal:  Am J Gastroenterol       Date:  1989-03       Impact factor: 10.864

6.  Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.

Authors:  B Wallmark; A Brändström; H Larsson
Journal:  Biochim Biophys Acta       Date:  1984-12-19

7.  Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

Authors:  P Unge; A Gad; H Gnarpe; J Olsson
Journal:  Scand J Gastroenterol Suppl       Date:  1989

8.  Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.

Authors:  E Fellenius; T Berglindh; G Sachs; L Olbe; B Elander; S E Sjöstrand; B Wallmark
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962
  8 in total
  18 in total

1.  Direct and indirect methods of measuring Helicobacter pylori drug susceptibility in vitro.

Authors:  A McLaren
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp.

Authors:  J E Sjøstrøm; T Kühler; H Larsson
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 3.  Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.

Authors:  Susan M Cheer; Amitabh Prakash; Diana Faulds; Harriet M Lamb
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.

Authors:  P D Midolo; J D Turnidge; J R Lambert; J M Bell
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

5.  Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.

Authors:  K Nagata; N Sone; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 6.  Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.

Authors:  A Fitton; L Wiseman
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

7.  Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.

Authors:  M Nakao; M Tada; K Tsuchimori; M Uekata
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

Review 8.  Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease.

Authors:  A Burette; Y Glupczynski
Journal:  Infection       Date:  1995       Impact factor: 3.553

Review 9.  Potent gastric acid inhibition in Helicobacter pylori eradication.

Authors:  Javier P Gisbert
Journal:  Drugs       Date:  2005       Impact factor: 9.546

10.  In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions.

Authors:  J E Sjöström; J Fryklund; T Kühler; H Larsson
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.